Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme (Q33416019)

26 July 2017

Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme (English)

1 reference

26 July 2017

1 reference

1 reference

4

David Mathieu

1 reference

26 July 2017

1

David Fortin

1 reference

26 July 2017

Pierre-Aurèle Morin

2

1 reference

26 July 2017

Francois Belzile

series ordinal

3

1 reference

26 July 2017

Francois-Michel Paré

series ordinal

5

1 reference

26 July 2017

language of work or name

1 reference

20 June 2014

1 reference

Journal of Neuro-Oncology

26 July 2017

1 reference

26 July 2017

119

1 reference

26 July 2017

2

1 reference

26 July 2017

397-403

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-014-1504-4

26 July 2017

0 references

cites work

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Diagnosis and treatment of recurrent high-grade astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Alternative chemotherapeutic agents: nitrosoureas, cisplatin, irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Change in pattern of relapse after antiangiogenic therapy in high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Astrocyte-endothelial interactions at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

The blood-brain barrier and cancer: transporters, treatment, and Trojan horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Blood-brain barrier delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Recent advances in blood-brain barrier disruption as a CNS delivery strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

The pathogenesis and treatment of brain metastases: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Effect of hyperosmotic solutions on human brain tumour vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Response assessment in neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

The blood-brain barrier: its influence in the treatment of brain tumors metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Up-front chemotherapy with fotemustine (F) / cisplatin (CDDP) / etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Pathology of high-dose intraarterial BCNU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Brain necroses after intraarterial chemotherapy and irradiation of malignant gliomas--a complication of both ACNU and BCNU?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Chemotherapy for malignant gliomas based on histoculture drug response assay : a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1504-4

Tissue concentration of systemically administered antineoplastic agents in human brain tumors

21 January 2018

1 reference

12 December 2020

A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma

1 reference

12 December 2020

Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy

1 reference

12 December 2020

Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.

1 reference

12 December 2020

A phase I study of cisplatin, temozolomide and thalidomide in patients with malignant brain tumors.

1 reference

12 December 2020

Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model

1 reference

12 December 2020

Bevacizumab is an active agent for recurrent high-grade glioma, but do we need randomized controlled trials?

1 reference

12 December 2020

Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening.

1 reference

12 December 2020

Testing of a hypothesis for osmotic opening of the blood-brain barrier

1 reference

12 December 2020

Ocular and orbital complications of intraarterial cisplatin. A case report.

1 reference

12 December 2020

Intracarotid cisplatin chemotherapy for high-grade astrocytomas.

1 reference

12 December 2020

10.1007/S11060-014-1504-4

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference